Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?

OBJECTIVES: To give an overview of the genetic and structural abnormalities occurring in fetuses with nuchal translucency (NT) measurement exceeding the 95th percentile at first‐trimester screening and to investigate which of these abnormalities would be missed if cell‐free fetal DNA (cfDNA) were us...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardi, Francesca, Bosschieter, Pien, Verheij, Joke, Go, Attie, Haak, Monique, Bekker, Mireille, Sikkel, Esther, Coumans, Audrey, Pajkrt, Eva, Bilardo, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027496/
https://www.ncbi.nlm.nih.gov/pubmed/31697852
http://dx.doi.org/10.1002/pd.5590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027496/
https://www.ncbi.nlm.nih.gov/pubmed/31697852
http://dx.doi.org/10.1002/pd.5590

Ejemplares similares